AU Patent

AU2005244650A1 — Pharmaceutical compositions comprising ZD6474

Assigned to Esteve Pharmaceuticals SA · Expires 2005-12-01 · 20y expired

What this patent protects

Patent listed against Caprelsa.

Drugs covered by this patent

Caprelsa (VANDETANIB) · Sanofi

Patent Metadata

Patent number: AU2005244650A1
Jurisdiction: AU
Classification: —
Expires: 2005-12-01
Drug substance claim: No
Drug product claim: No
Assignee: Esteve Pharmaceuticals SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.